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Long-chain acyl-CoA synthetase-1 (ACSL1) contrib-
utes 80% of total ACSL activity in adipose tissue
and was believed to be essential for the synthesis
of triacylglycerol. We predicted that an adipose-
specific knockout of ACSL1 (Acsl1A/) would be lip-
odystrophic, but compared to controls, Acsl1A/
mice had 30% greater fat mass when fed a low-fat
diet and gained weight normally when fed a high-fat
diet. Acsl1A/ adipocytes incorporated [14C]oleate
into glycerolipids normally, but fatty acid (FA) oxida-
tion rates were 50%–90% lower than in control
adipocytes and mitochondria. Acsl1A/ mice were
markedly cold intolerant, and b3-adrenergic agonists
did not increase oxygen consumption, despite nor-
mal adrenergic signaling in brown adipose tissue.
The reduced adipose FA oxidation and marked cold
intolerance of Acsl1A/ mice indicate that normal
activation of FA for oxidation in adipose tissue
in vivo requires ACSL1. Thus, ACSL1 has a specific
function in directing the metabolic partitioning of
FAs toward b-oxidation in adipocytes.
INTRODUCTION
Dysfunctional lipid metabolism underlies the development of
obesity and obesity-related complications such as hepatic stea-
tosis, diabetes, and heart disease. Although the mechanisms
that regulate the cellular uptake, activation, and metabolism of
fatty acids (FAs) are not fully understood, nearly all pathways
of FA metabolism require the acyl-CoA synthetase-mediated
conversion of FAs to acyl-CoAs (FA + CoA + ATP/ acyl-CoA +
AMP + PPi). Acyl-CoAs have multiple fates, including use in
complex lipid formation and lipid remodeling, effects on signal
transduction, activation of transcription factors, and oxidation
to provide cellular energy. Long-chain acyl-CoAs are formed
by a family of five acyl-CoA synthetases (ACSL)—ACSL1,
ACSL3, ACSL4, ACSL5, and ACSL6—and by several FA trans-port proteins (FATPs). ACSL isoenzymes are intrinsic membrane
proteins whose active sites face the cytosol to produce acyl-
CoAs, which are either partitioned into the facing membrane
monolayer, where they can encounter downstream metabolic
enzymes (Coleman and Bell, 1978; Mannaerts et al., 1982), or
transported to different organelles by the cytosolic acyl-CoA
binding protein (Stremmel et al., 2001). The ability of amphipathic
acyl-CoAs tomove freely within a singlemembranemonolayer or
to be transported to distant membranes should render all acyl-
CoAs metabolically equivalent, no matter which ACSL isoen-
zyme catalyzes their formation. Yet gain-of-function studies
suggest that each of the ACSL isoform has a distinct function
in directing acyl-CoAs to one or more specific downstream path-
ways (Li et al., 2006; Mashek et al., 2006b).
The functions of the ACSLs are of particular interest in adipose
tissue because of the central role that white adipose tissue (WAT)
plays in energy storage and that brown adipose tissue (BAT)
plays in energy dissipation. In WAT, Acsl1 mRNA is the most
abundantly expressed isoform, with relatively lower expression
of Acsl3, 4, and 5 (Mashek and Coleman, 2006). Acsl1 mRNA
in liver is upregulated by PPARa ligands (Martin et al., 1997),
whereas its mRNA in WAT is increased by PPARg agonists
(Gerhold et al., 2002; Shimomura et al., 1993). In differentiating
3T3-L1 adipocytes, ACSL-specific activity and mRNA expres-
sion increase 100- and 160-fold, respectively (Coleman et al.,
1978; Marszalek et al., 2004), whereas the expression of the
other ACSL isoenzymes remains unchanged (Oikawa et al.,
1998). This induction of Acsl1 expression suggested that
ACSL1 is upregulated as part of the program of adipocyte differ-
entiation culminating in triacylglycerol (TAG) synthesis and
storage. Consistent with this interpretation, an expression clon-
ing strategy designed to find cDNAs that augment FA uptake and
incorporation into TAG cloned and identified ACSL1 (Schaffer
and Lodish, 1994). Further, overexpressed ACSL1 in 3T3-L1
adipocytes increases FA uptake and incorporation into TAG
(Gargiulo et al., 1999; Richards et al., 2006; Souza et al., 2002).
In order to examine the putative role of ACSL1 in TAG synthesis,
we created a mouse deficient in adipose ACSL1 and predicted
that these mice would be unable to synthesize and store TAG
in adipocytes. Surprisingly, however, the Acsl1A/ mice had
normal fat stores, but severely impaired adipose FA oxidation,
suggesting not only that ACSL1 catalyzes the initial requiredCell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc. 53
Figure 1. Generation of Mice that Lack ACSL1
Specifically in Adipose Tissue
(A and B) Representative immunoblot against ACSL1
protein (A) and ACSL activity (B) in control and Acsl1A/
liver, brown, gonadal, and inguinal adipose of 20-week-
old mice, n = 5–7.
(C and D) ACSL isoenzyme mRNA expression in gonadal
adipose (C) and brown adipose (D) from 20-week-old
control and Acsl1A/ mice, n = 6. Data represent
mean ±SEM; *p% 0.05 versus control.
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Adipose-Specific Acyl-CoA Synthetase-1 Knockoutstep in FA oxidation, but also that it specifically directs FA toward
mitochondrial b-oxidation.
RESULTS
Generation of Mice that Lack ACSL1 Specifically
in Adipose Tissue
Mice with loxP sequences inserted on either side of exon 2 in the
Acsl1 gene (Li et al., 2009) and backcrossed to the C57BL/6
strain six times were crossed with mice in which Cre expression
is driven by the aP2 promoter (B6.Cg-Tg [Fabp4-cre] 1Rev/J;
Jackson Laboratory; Bar Harbor, ME) to generate adipose-
specific Acsl1 knockout mice (Acsl1A/). Littermates lacking
the Cre gene (Acsl1flox/flox) were used as controls.
ACSL1 protein was virtually absent in brown, gonadal, and
inguinal adipose tissue from Acsl1A/ mice (Figure 1A). ACSL-
specific activity was 80% lower than in controls, confirming
that ACSL1 is, functionally, the major ACSL in adipose tissue
(Figure 1B), with the remaining 20% of ACSL activity catalyzed
by other ACSL isoenzymes in adipocytes and all ACS enzymes
in stromovascular tissue (Mashek et al., 2006a). Confirming the
tissue specificity of the knockdown, ACSL1 protein and total
ACSL-specific activity were unaffected in Acsl1A/ liver (Fig-
ures 1A and 1B). Real-time PCR showed nearly absent expres-
sion of Acsl1 mRNA in Acsl1A/ gonadal and BAT, but
unchanged expression of the other four Acsl isoenzymes and
a 50% reduction in Fatp1 mRNA, a related ACS (Figures 1C
and 1D). Thus, other acyl-CoA synthetases did not compensate
for the loss of ACSL1.
Acsl1A/Mice Have Increased FatMass and Synthesize
TAG Normally
Despite the 80% loss of adipose ACSL activity, Acsl1A/ mice
had increased adiposity. When fed a 10% fat diet, Acsl1A/
body weights were similar to controls (Figure 2A), but MRI anal-
ysis showed that the mice had 30% more body fat (Figure 2B).
Consistent with the MRI data, gonadal fat depot weights were54 Cell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc.H
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e40% greater in mice fed chow or 10% fat diets
(Figure 2C). Gonadal adipose tissue histology,
adipocyte size, glycerol-3-phosphate acyltrans-
ferase (GPAT)-specific activity, and AMPK
phosphorylation were similar between geno-
types (Figures 2D–2G). No genotype differences
in liver or BAT weights were observed.
No diet-related differences were observed
between genotypes in plasma glucose, FA,
cholesterol, or insulin concentrations (Table S1).owever, plasma TAG concentrations were 17% lower in
csl1A/mice. A 45% fat diet resulted in weight gain, adiposity,
nd insulin resistance that was similar in both genotypes (Fig-
re 2A and Table S1). Loss of ACSL1 could theoretically change
e cellular content and ratio of its FA substrate and acyl-CoA
roduct, thereby altering the availability of ligands for PPARg
nd PPARa (Berger and Moller, 2002; Hostetler et al., 2005);
owever, target genes of these transcription factors did not
hange significantly in Acsl1A/ gonadal WAT (Table S2).
When fed a low-fat diet, the amount of phospholipid (PL)
xtracted from epididymal WAT was similar in both genotypes,
ut Acsl1A/ WAT contained more TAG, diacylglycerol (DAG),
nd FA per fat pad (Figure 2H). With the high-fat diet, no differ-
nces were present between control and Acsl1A/ lipid classes
epididymal WAT. BAT from Acsl1A/ and control mice fed
ither diet also contained similar amounts of all lipid classes (Fig-
res S1A and S1B). Thus, lack of ACSL1 did not impair adipose
AG accumulation.
Confirming normal TAG synthesis in both isolated white
onadal adipocytes and cultured primary white adipocytes
om control andAcsl1A/mice, the rates of [1-14C]oleate incor-
oration into TAG and PL were similar, indicating that the lack of
CSL1 did not impair FA incorporation into complex lipids
igures 2I and 2J). Thus, despite greater than 100-fold increases
Acsl1 mRNA and ACSL-specific activity during fat cell differ-
ntiation (Coleman et al., 1978; Marszalek et al., 2004), TAG syn-
esis does not require FA activation by ACSL1. The increased
t mass did not result from impaired lipolysis, because in 24 hr
sted mice and in media from WAT explants with or without
xposure to lipolytic stimuli (Figures 2K–2M and Table S3), FA
nd glycerol release were similar between genotypes.
ifferences in FA Species Content in Adipose Tissue
e did not expect to find major changes in FA species, because
ach of the purified ACSL isoenzymes in vitro can activate awide
nge of long-chain, saturated, and unsaturated FA (Oikawa
t al., 1998). However, compared to controls, Acsl1A/ mice
Figure 2. Acsl1A/ Mice Have Increased Fat Mass
(A) Body weight from 6 to 24 weeks of age in mice fed LFD or HFD, n = 10–15.
(B) Total body fat measured by MRI in 26-week-old control and Acsl1A/ male mice, n = 5–7.
(C) Fat depot weight as a percent of body weight (BW) in 20- to 26-week-old control and Acsl1A/ male mice, n = 10–15.
(D and E) Representative sections from control and Acsl1A/ epididymal WAT (D) and mean cell sizes from sections stained for hematoxylin and eosin (E),
scale bars = 50 mM.
(F) AMPK phosphorylation, relative to total AMPK, from control and Acsl1A/ inguinal adipose, n = 4–5.
(G) Total GPAT activity in control and Acsl1A/ gonadal adipose, n = 6.
(H) Lipid content was measured in control and Acsl1A/ epididymal WAT in 6-month-old male mice fed LFD or HFD for 4.5 months, n = 5.
(I and J) The rate of [1-14C]oleate incorporation into glycerolipids was measured in mature epididymal adipocytes, n = 6 (I), or cultured primary adipocytes from
control and Acsl1A/ mice, n = 3 (J).
(K) Plasma FA was measured in control and Acsl1A/ mice fasted for 4 or 24 hours, n = 6–8.
(L and M) FA (L) or glycerol (M) release from control and Acsl1A/ gonadal adipocyte explants was measured basally or with 10 mM isoproterenol (Iso), n = 8.
(N) Acid soluble metabolites (ASM) and CO2 were quantified in control (C) and Acsl1
A/ (A/) mature epididymal adipocytes, n = 6. HFD, high-fat diet; LFD,
low-fat diet; TAG, triacylglycerol; DAG, diacylglycerol; PL, phospholipids; FA, fatty acids. Data represent mean ±SEM. *p % 0.05 versus control; #p % 0.05
chow or LFD versus HFD within genotype.
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Adipose-Specific Acyl-CoA Synthetase-1 Knockoutfed both the low-fat and high-fat diets contained 20%–30% less
18:2n6 in TAG from brown and gonadal white adipose (Figures
S1C and S1D). The TAG fraction of BAT from Acsl1A/ mice
was composed of 15% more 16:0 than controls fed the low-fat
diet (Figure S1E). In Acsl1A/ BAT, the PL fraction from mice
fed the high-fat diet contained 30% more 16:0 and 15%, 22%,
and 14% less 18:0, 18:2n6, and 20:4n6, respectively, than
controls (Figure S1F). No other differences in the major FA
species were observed. These small but statistically significant
alterations in lipid composition of adipose tissues suggest that
ACSL1 does contribute to the relative content of esterified FA
species in neutral lipids and PLs, despite theminimal differences
in FA preference observed in vitro.
FA Oxidation Was Impaired in White Adipocytes
from Acsl1A/ Mice
Compared to mature adipocytes isolated from control mice, the
rate of [1-14C]oleate incorporation into CO2 and acid soluble
metabolites (ASM) was 50% lower in Acsl1A/ adipocytes (Fig-
ure 2N). CO2 and ASM represent complete and incomplete
products of FA oxidation; thus, the 50% reduction of FA incorpo-
ration into these oxidative products reflects reduced b-oxidation
and suggests that impaired FA catabolism could have caused
the larger WAT depots in the Acsl1A/ mice.
Decreased FA Oxidation Rendered Acsl1A/ Mice
Cold Intolerant
FA oxidation increases markedly in BAT during cold exposure.
To generate heat and maintain normal body temperature, ATP
production is reduced when activated uncoupling protein
(UCP1) increases the flux of protons through the electron trans-
port chain and dissipates the mitochondrial proton gradient
(Lowell and Spiegelman, 2000). Fasted wild-typemice canmain-
tain their body temperature above 35C for as long as 24 hr at
4C (Cohen et al., 2005). In striking contrast, however, the body
temperature of the Acsl1A/ mice fell below 30C within 3 hr
(Figure 3A). During cold exposure, both genotypes shivered simi-
larly, and gastrocnemius total ACSL activity (Figure S4A) and
Acsl1 mRNA abundance (data not shown) did not change in
Acsl1A/ mice. In shivering muscle, fuel preference and the
contribution of muscle heat to total body heat remain unclear
(Haman, 2006); however, plasma FFA and VLDL were not limit-
ing for either Acsl1A/ skeletal muscle or BAT (Figures 6C
and 6D).
Direct measurements of FA oxidation rates in BAT homoge-
nates from Acsl1A/mice showed that the rate of [1-14C]palmi-
tate incorporation into CO2 and ASM was 36% lower than
controls (Figure S5C). Because label dilution occurs when FA
oxidation is measured in cells with a high lipid content, we
confirmed this oxidation defect by monitoring O2 consumption
in conscious Acsl1A/ and control mice in Oxymax chambers.
Whole-body O2 consumption normally increases in response
to adrenergic stimuli and reflects an increase in electron trans-
port chain activity. Isoproterenol, a nonspecific b-adrenergic
receptor agonist, increased O2 consumption 51% in control
mice, but only 18% in Acsl1A/ mice (Figure 3B). This blunted
response indicates that whole-body oxidation is diminished.
When CL-316243, an adipose-specific, b3-adrenergic receptor
agonist (Yoshida et al., 1994) was injected, O2 consumption56 Cell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc.increased 30% in control mice, but only 2% in Acsl1A/ mice,
showing that the block in adrenergic-mediated oxidation was
adipose specific (Figures 3B and S5B).
In mitochondria from Acsl1A/ BAT, the production of CO2
from [1-14C]palmitate oxidation was reduced 62% (Figures 3E
and 3G), and this reduction in mitochondrial FA oxidation corre-
lated directly with the amount of mitochondrial ACS activity and
ACSL1 protein present in each of three mitochondrial prepara-
tions (Figures 3F, S4E, and S4F). In contrast, CO2 production
from [1-14C]pyruvate oxidation was similar to that of control
mitochondria, showing that Acsl1A/ BAT mitochondria are
functional for substrates other than FA. The 31% reduction in
[1-14C]palmitoyl-CoA oxidation (Figure 3G) suggests that FA
oxidation may require the generation of acyl-CoA at the mito-
chondrial membrane and/or that the mechanism by which
ACSL1 directs its acyl-CoA product towardmitochondrial oxida-
tion may be partially disrupted by homogenization. The rate of
oxygen consumption in control and Acsl1A/BATmitochondria
was similarly increased by UCP1-dependent pyruvate stimula-
tion, and in both genotypes, guanidine diphosphate (GDP)
effectively reduced oxygen consumption by inhibiting UCP1
(Figure S4). These data show that ACSL1-deficient BAT mito-
chondria have full UCP1 activity and that Acsl1A/ cold intoler-
ance is not due to impaired UCP1 function. Taken together,
these data from live mice, BAT homogenates, and isolated mito-
chondria indicate that cold intolerance of the Acsl1A/ mice
resulted from impaired FA oxidation and show that ACSL1 is
absolutely required for cold-adaptive thermogenesis in BAT.
After 4 hr at 4C, BAT from control mice depleted its lipid
droplets, but lipid droplets were retained in Acsl1A/ BAT
(Figure 3C). Control mice lost 50% of BAT lipid stores after
4 hr of cold exposure, whereas the TAG content in Acsl1A/
BAT did not change (Figure 3D). Liver and WAT histology was
similar at 21C and 4C in both genotypes (data not shown).
Although TAG retention in Acsl1A/ BAT after cold exposure
could be due to impaired lipolysis, the increase in plasma FA
and glycerol in cold-exposed Acsl1A/ mice is consistent
with active TAG lipolysis in WAT, and in differentiated primary
brown adipocytes from Acsl1A/ mice, the release of FA into
the media was greater than controls under basal conditions and
similar after adrenergic stimuli, demonstrating that Acsl1A/
brown adipocytes lipolyzed intracellular TAG normally (Fig-
ure 3I). Surprisingly, compared to control cells, glycerol release
in Acsl1A/ brown adipocytes was blunted by 50% after
adrenergic stimulation (Figure 3H). Reduced release of glycerol
by Acsl1A/ brown adipocytes could result from increased
conversion to glycerol-3-P for lipid synthesis or because the
glycerol was oxidized as an alternative substrate. After 3 hr
of isoproterenol exposure, both Acsl1A/ and control differen-
tiated brown adipocytes had similar 33% reductions in
[14C]oleate-labeled TAG (Figure 3J), indicating that both lipol-
ysis and FA re-esterification after lipolysis were unaffected by
ACSL1 deficiency. [1-14C]Oleate incorporation into ASM was
90% lower in Acsl1A/ brown adipocytes than in controls, con-
sistent with the marked decrease in FA oxidation (Figure 3K).
Thus, in cold-exposed Acsl1A/ BAT, the retention of lipid
droplets probably reflects an influx of FAs that cannot be
oxidized without ACSL1 and are therefore incorporated into
neutral lipid.
Figure 3. Acsl1A/MiceAre Cold Intolerant
Due to Impaired FA Oxidation
(A) Body temperature was measured in fasted
control and Acsl1A/ male mice exposed to a
4C environment for 4 hr, n = 14–16.
(B) Control and Acsl1A/ male mouse O2 con-
sumption was monitored in a metabolic chamber
for 3 hr before and after injection of isoproterenol
(Iso) or CL-316243 (CL) (10 mg/kg), n = 6–8.
(C) Representative BAT histology stained for
hematoxylin and eosin is shown in control and
Acsl1A/ mice before and after cold exposure
for 2–4 hr when Acsl1A/ body temperature
reached 30C; scale bars = 50 mm.
(D) TAG content was quantified in BAT from
control and Acsl1A/ mice fasted at 21C or at
4C for 4 hr, n = 5–6.
(E–G) BATmitochondrial [1-14C]palmitate (E and F)
and [1-14C]palmitoyl-CoA and [1-14C]pyruvate (G)
oxidation into CO2 was measured in control and
Acsl1A/ mice, n = 3. Control (C) and Acsl1A/
(A/) ACSL1 immunoblot and protein quantifica-
tion are shown, and CO2 production was mea-
sured from [1-14C]palmitate in three mitochondrial
preparations (A–C) relative to control. In control
and Acsl1A/ primary brown adipocytes cultured
with or without 10 mM isoproterenol, mg glycerol/
mg protein/hr (H) and FA release (I) and the
incorporation of [1-14C]oleate into TAG (J) and
ASM (K) were measured, n = 3. Data repre-
sent mean ± SEM. *p % 0.05 versus control;
#p% 0.05 21C versus 4C within genotype.
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Genes Was Normal in Acsl1A/ Mice
b-adrenergic signaling during cold exposure induces the expres-
sion of genes that activate mitochondrial biogenesis, heat
production, and oxidative capacity. At 4C, both control and
Acsl1A/ mice upregulated mRNA levels of Ucp1 and PPARg
coactivator-1a (Pgc-1a) 2- and 30-fold, respectively (FiguresCell Metabolism 12,4A and 4B). These increases indicate
that adrenergic-stimulated signaling was
unimpaired in Acsl1A/ BAT (Bachman
et al., 2002).
Compared to controls, the mRNA
expression of muscle-type carnitine pal-
mitoyltransferase-1 (mCpt1) was signifi-
cantly higher in the Acsl1A/ BAT at
21C, and cytosolic thioesterase-1 (Cte1)
was significantly higher after cold expo-
sure, suggesting that the lack of ACSL1
might increase cellular FA to activate
PPARa-mediated transcription (Fig-
ure 4C). However, the expression of other
PPARa-regulated genes, medium-chain
acyl-CoA dehydrogenase (Mcad), acyl-
CoA oxidase (Aox), and Ppara did not
differ between the genotypes, suggesting
that the lack of ACSL1 does not affect all
PPARa target genes with or without 4 hr
of cold exposure.Because Acsl1A/ BAT retained lipid droplets after cold
exposure, we measured genes that encode lipogenic and
substrate-producing proteins that would normally increase
during cold exposure. Acsl1A/ BAT should have been able to
lipolyze and/or endocytose circulating TAG-rich lipoproteins
and to make use of these exogenous FA sources, because the
lipogenic genes lipoprotein lipase (Lpl) and VLDL-receptor53–64, July 7, 2010 ª2010 Elsevier Inc. 57
Figure 4. Thermogenic Regulation of Genes Was Normal in Acsl1A/ Mice
(A–E) BATmRNA levels were quantified by real-time PCR for genes of adrenergic regulation (A and B), FA oxidation (C), lipogenesis (D), and acyl-CoA synthetases
(E) in BAT frommale control and Acsl1A/mice without or with 4C exposure, relative to cyclophilin A expression, n = 6. Data represent mean ±SEM; *p% 0.05
Acsl1A/ versus control; #p% 0.05 21C versus 4C within genotype. A, Agpat; G, Gpat.
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Adipose-Specific Acyl-CoA Synthetase-1 Knockout(Vldl-r) had similar expression patternswith or without cold expo-
sure in both genotypes (Figure 4D). Similarly, 1-acylglycerol-
3-phosphate O-acyltransferase-1 (Agpat1) increased in both
genotypes, as did Gpat4, a major GPAT in BAT (Vergnes et al.,
2006). These data suggest that the retained lipid droplets in
Acsl1A/BATwere not caused by abnormal regulation of genes
required for TAG synthesis.
BAT expression of Acsl3 and Acsl4 (but not Acsl1, Acsl5, or
Acsl6) was upregulated in both genotypes in response to cold
(Figure 4E), and long-chain acyl-CoA content in cold-exposed
Acsl1A/ BAT did not differ from controls. These data indicate
that acyl-CoAs synthesized by other ACSL isoenzymes were
unavailable for b-oxidation and that maintenance of normal
body temperature requires acyl-CoAs synthesized by ACSL1.
Acyl-Carnitines Were Reduced in Acsl1A/ BAT
To gain further insight into the consequences of ACSL1 defi-
ciency, we used mass spectrometry to profile a targeted array
of intermediary metabolites. Long-chain acyl-carnitines accu-
mulate when their production by mitochondrial CPT1 exceeds
their flux through b-oxidation (Makowski et al., 2009). In wild-
type mice, cold exposure lowered major long-chain acyl-carni-
tine species and increased b-hydroxybutyryl-carnitine (4-OH),
a strongmarker of increased b-oxidation and ketonemetabolism
(Figures 5A–5C and S2B). This profile is consistent with activa-
tion of mitochondrial uncoupling and a shift in flux limitation
from long-chain acyl-CoA dehydrogenase to short-chain
b-hydroxy-acyl-CoA dehydrogenase. In contrast, under thermo-
neutral conditions, BAT concentrations of most long-chain acyl-
carnitine species were markedly lower in Acsl1A/ mice com-
pared to controls. Taken together with our measures of FA
oxidation, this finding suggests impaired delivery of long-chain58 Cell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc.acyl-CoAs to CPT1. During cold exposure, although Acsl1A/
BAT had increases in several long- and short-chain acyl-carni-
tines, these remained substantially lower than in controls
(Figures 5A–5C, S2B, and S2C). BAT levels of acetyl-carnitine
(C2), which is derived from acetyl-CoA, were similar between
genotypes, suggesting that increased catabolism of glucose
and/or amino acids in the Acsl1A/mice partially compensated
for impaired FA oxidation.
In control mice, the BAT content of most organic acids was
maintained during cold exposure, with the exceptions of lactate
and succinate, which declined (Figures 5D–5F). Compared to
controls, lactate was lower in Acsl1A/ mice, regardless of
temperature, consistent with enhanced pyruvate oxidation and
a shift in cellular redox state. The lower levels of succinate in
Acsl1A/ BAT may reflect disinhibition of succinate dehydroge-
nase (complex II). Notably, BAT levels of several amino acid-
derived CoA species (propionyl-CoA, succinyl-CoA, 3-methyl-
crotonyl-CoA, isovaleryl-CoA) were elevated in Acsl1A/
compared to control mice, principally during cold exposure
(Figures 5G and 5H). These elevations are consistent with
a compensatory increase in protein catabolism and amino acid
oxidation. Supporting this interpretation, the concentrations of
branched chain and anaplerotic amino acids (valine, leucine/iso-
leucine, tyrosine) were elevated in the Acsl1A/ mice, whereas
alanine, the major gluconeogenic amino acid, was decreased
(Figures 5I and 5J).
Hypoglycemia and Hyperlipidemia in Acsl1A/ Mice
after Adrenergic Stimuli
Plasma glucose decreased in both genotypes during cold expo-
sure; however, the plasma glucose concentration in Acsl1A/
mice fell 58% more than in the controls (Figure 6A). Similarly,
Figure 5. Long-Chain Acyl-Carnitines Were Reduced in Acsl1A/ Brown Adipose Tissue
(A–C) Free, acetyl-, and acyl-carnitine content in BAT with and without cold exposure at 4C.
(D–J) Lactate (D) and citric acid cycle intermediates (E and F), short-chain acyl-CoA (G and H), amino acids (I), and total amino acid content (J) in BAT with and
without 4C exposure, n = 7. DC, dicarboxylated acyl-carnitines; OH, hydroxylated acyl-carnitines; Asx, aspartate/asparagine; Gsx, glutamate/glutamine.
Data represent mean ±SEM. *p% 0.05 versus control; #p% 0.05 21C versus 4C within genotype (n = 6–10).
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Adipose-Specific Acyl-CoA Synthetase-1 Knockoutafter b-adrenergic stimulation with isoproterenol or CL-316243,
Acsl1A/ plasma glucose was 36% or 19% lower, respectively,
than controls. The larger decrements in glucose in Acsl1A/
mice after cold exposure and b-adrenergic agonists, but not
after 24 hr of fasting (Table S3), suggest enhanced glucose use
by Acsl1A/ BAT. Plasma glycerol increased similarly in both
genotypes, both during cold exposure and after isoproterenol
injection; however, in response to CL-316243, circulating glyc-
erol increased 14% in controls, but decreased 15% in Acsl1A/
mice, consistent with the reduced glycerol release by Acsl1A/primary brown adipocytes (Figure 3H). Again, the decrease in
released glycerol from BAT may reflect its increased use as an
alternate oxidative substrate (Figure 6B). FA concentrations after
cold exposure or CL-316243 were 30% higher in Acsl1A/mice
compared to controls (Figure 6C); this increase in plasma FA
induced by b-adrenergic stimuli, but not after 24 hr of fasting,
provides additional evidence for intact Acsl1A/ lipolytic activity
and is consistent with diminished use of FA for oxidation in BAT.
In response to cold exposure, plasma TAG, another potential
source of FA for BAT metabolism, decreased 41% in controlCell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc. 59
Figure 6. Plasma Metabolites and BAT Acyl-CoAs in Acsl1A/Mice
after Adrenergic Stimuli
(A–D) Plasma glucose (A), glycerol (B), FA (C), and TAG (D) from control and
Acsl1A/ mice fasted for 4 hr at 21C or 4C or before (T0) and 3 hr after
isoproterenol (Iso) or CL-316243 (CL) injection (10 mg/kg), n = 6–8.
(E) Sum of long-chain acyl-carnitines (C14-C20) in control (C) and Acsl1A/
(A/) with or without cold exposure for 2–4 hr. Data represent mean ±SEM;
*p% 0.05 versus control; #p% 0.05 21C or T0 versus treated within genotype.
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mRNA (Figures 6D and 4E), probably as a result of hepatic
recycling of the elevated plasma FA into VLDL.
DISCUSSION
After a long-chain FA enters a cell, its metabolic fate is deter-
mined by the metabolic demands of the cell, the availability60 Cell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc.of other energy substrates, PPARa- and PPARg-mediated
changes in enzymes of complex lipid synthesis and b-oxidation
(Qi et al., 2000), and the relative content of intracellular AMP,
which controls AMP-activated kinase and, thus, CPT1 (Ruder-
man et al., 2003). Here, we show that ACSL1 contributes criti-
cally to adipose FA metabolism by catalyzing the formation of
acyl-CoAs that are used for b-oxidation. If all acyl-CoAs were
metabolically equivalent, one would expect that the rates of
acyl-CoA incorporation into all metabolic end products would
be diminished equally and that adipose from Acsl1A/ mice
would have impairments in both FA oxidation and complex lipid
synthesis. However, the role of adipose ACSL1 in catalyzing the
key initial step in FA oxidation is supported by the normal rate of
FA incorporation into complex lipids and the 50%–90% reduc-
tion in the rate of FA oxidation in white and brown adipocytes
and in BAT mitochondria from Acsl1A/ mice, together with
the inability of Acsl1A/ BAT to oxidize FA for thermogenesis.
Although the content of acyl-CoA in BAT was similar in control
and Acsl1A/ mice, these acyl-CoAs were unavailable for
b-oxidation in the absence of ACSL1. The inability of the other
ACSL isoenzymes to direct acyl-CoAs toward b-oxidation, espe-
cially during the physiological stress of acute cold exposure in
BAT, indicates that ACSL1 has a distinct function in partitioning
FA and that the other ACSL isoenzymes in adipose tissue cannot
compensate for its absence. Our data also suggest that the
importance of FA oxidation in WAT has been underestimated.
Acute cold exposure stimulates norepinephrine release, which
induces adipocyte TAG lipolysis via b-adrenergic receptors
(Figure 7). In BAT, lipolyzed FA activates UCP1 to dissipate the
mitochondrial proton gradient; activation of UCP1 results in
energy expended in the form of heat rather than ATP generation.
Thermogenesis is maintained primarily through FA oxidation;
glucose cannot maintain euthermia at 4C in knockout mice defi-
cient in short-chain, medium-chain, long-chain, or very-long-
chain acyl-CoA dehydrogenases (Guerra et al., 1998; Schuler
et al., 2005; Tolwani et al., 2005). When Acsl1A/ mice were
exposed to a 4C environment, their body temperature dropped
below 30C within 2–5 hr, despite the normal increase in BAT
catecholamine-regulated genes. Because no method exists to
distinguish between FA and acyl-CoAs as activators of UCP1
(Strieleman et al., 1985; Strieleman and Shrago, 1985), the actual
activator of UCP1 could be acyl-CoA generated by ACSL1. If this
were true, Acsl1A/ mice would be cold intolerant because
UCP1 is not activated. However, impaired acyl-CoA oxidation
was observed directly in BAT mitochondria, brown primary
adipocytes, and BAT homogenates and in isolated gonadal
adipocytes, which do not require UCP1 activation. In addition,
compared to control mice, the in vivo rate of oxygen consump-
tion of Acsl1A/ mice at 21C was 60% lower, and when stim-
ulated by isoproterenol or by an adipose-specific b3-adrenergic
receptor agonist was more than 90% lower, indicating reduced
flux through the electron transport chain and reduced adipose
mitochondrial oxidation. Finally, Acsl1A/ UCP1 uncoupling
was activated by pyruvate and inhibited by GDP, indicating nor-
mally activated UCP1 (Figure S4) (Shabalina et al., 2004).
The role that FA oxidation plays in WAT has not been exten-
sively investigated (Deveaud et al., 2004). Apart from the normal
demands of cellular metabolism, adipocytes require energy both
to synthesize FA de novo and to activate FA to acyl-CoAs for
Figure 7. BAT Fatty Acid Metabolism in Cold-Exposed Mice
When norepinephrine activates b-adrenergic receptors, activated protein kinase A (PKA) induces PGC-1a in brown adipocytes, which, together with FA, activates
transcription factors that upregulate genes required for mitochondrial oxidative and thermogenic functions. PKA also activates hormone-sensitive lipase (HSL),
which lipolyzes TAG in white and brown adipose cells. FAs released from WAT and from VLDL (via lipoprotein lipase [LPL]) enter brown adipocytes and are acti-
vated by ACSLs to form acyl-CoAs that can be esterified to form TAG or are oxidized. FAs lipolyzed from TAG stores in brown adipocytes are activated by ACSL1,
enter mitochondria, and are oxidized. FAs also activate UCP1, which uncouples the mitochondrial proton gradient, producing heat.
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reduced FA oxidation 50% and resulted in a 30% increase in
adipose mass. Although it is possible that ACSL1 is not the
sole isoform in WAT that can activate the FA that is targeted
toward b-oxidation, we attribute the increased WAT mass in
Acsl1A/ mice to diminished use of FA for energy generation
within WAT itself, because mice that cannot use BAT for thermo-
genesis are not obese unless they are kept at a thermoneutral
temperature (Lodhi and Semenkovich, 2009). The potential
importance of FA b-oxidation in WAT is supported by the obser-
vation that mitochondrial proteins increase 20- to 30-fold in WAT
after treatment with a PPARg agonist or during 3T3-L1 adipocyte
differentiation (Shi et al., 2008; Wilson-Fritch et al., 2003). The
physiological stimuli that increase the rate of FA oxidation in
WAT are unknown, but treating 3T3-L1 cells with an adipocyte-
differentiation cocktail plus rosiglitazone increases the content
of both mitochondrial ACSL1 protein and proteins required for
FA oxidation, suggesting coordinated regulation (Wilson-Fritch
et al., 2004).
The AMP generated by the ACSL1 reaction may activate AMP
kinase in 3T3-L1 adipocytes stimulated with isoproterenol or for-
skolin (Gauthier et al., 2008; Lobo et al., 2009). However, AMPK
phosphorylation was not altered in Acsl1A/ WAT (Figure 2F),
and acute cold exposure does not activate AMPK in BAT
(Mulligan et al., 2007). Thus AMPK activity does not mediate
the cold intolerance of Acsl1A/ mice. When RNAi was used
to knock down ACSL1 in 3T3-L1 adipocytes (Lobo et al.,
2009), the cells increased FA efflux during lipolysis, suggestingthat ACSL1 activates and re-esterifies FA that has been lipolyzed
from intracellular TAG. Our results suggest a different function.
If re-esterification were impaired in Acsl1A/ adipose, one
would expect that an acute cold challenge would deplete TAG
stores in BAT and that WAT would contain less TAG. However,
Acsl1A/mice retained their BAT lipid stores at 4C, suggesting
that re-esterification was not diminished. Further, in Acsl1A/
primary brown adipocytes, loss of 14C-labeled FA in TAG after
lipolytic stimuli was similar to controls, and in white adipose
explants, the release of FA and glycerol was similar between
genotypes with or without lipolytic stimuli. Although the
increased release of FA from brown adipocytes (Figure 3I) could
suggest diminished re-esterification under basal conditions,
both genotypes had similar losses of [14C]oleate that had been
incorporated into TAG and in the release of FA under lipolytic
conditions. These data confirm normal rates of lipolysis and,
together with the cold intolerance and increased adipose
mass of theAcsl1A/mice, are consistent with normal FA re-es-
terification. In fact, a proteomics study demonstrates marked
differences in the protein expression of mitochondria from
3T3-L1 adipocytes and those from primary mouse adipocytes,
so it is not surprising to find functional differences in these two
cell types (Forner et al., 2009; Lobo et al., 2009).
Based on the dramatic increase in Acsl1 mRNA and total
ACSL activity in differentiating 3T3-L1 adipocytes (Coleman
et al., 1978; Marszalek et al., 2004), we had predicted that adipo-
cyte ACSL1 would catalyze the synthesis of acyl-CoAs destined
for TAG synthesis. However, both mature and primaryCell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc. 61
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rated [14C]oleate into TAG normally, and Acsl1A/ fat depots
were larger than those of controls. Further, Acsl1A/ mice
became obese and insulin resistant when fed a high-fat diet.
Although the lack of ACSL1 in WAT and BAT reduced ACSL-
specific activity by 80%, the remaining ACSL activity, derived
from other ACSL and FATP isoenzymes, was able to synthesize
acyl-CoAs directed toward normal TAG biosynthesis. Thus,
ACSL1 is not required for TAG synthesis in adipose tissue.
How does ACSL1 channel acyl-CoAs toward b-oxidation? In
adipocytes, subcellular fractionation studies identified ACSL1
on the plasma membrane, microsomes, and mitochondria (Gar-
giulo et al., 1999); on GLUT4 vesicles (Sleeman et al., 1998); and
on lipid droplets (Brasaemle et al., 2004). In BAT and WAT,
ACSL1 protein has also been found in mitochondria fractions
(Forner et al., 2009). However, even if ACSL1 were located solely
on the mitochondrial outer membrane, its ability to channel its
acyl-CoA product toward b-oxidation remains difficult to
conceptualize. Long-chain acyl-CoAs are water-soluble, amphi-
pathic molecules that can partition into membranes or bind to
cytosolic carriers like acyl-CoA binding protein. Thus, acyl-
CoAs should be able to move freely within the membrane mono-
layer at their site of synthesis and to travel between different
organelles. Direct physical interaction of ACSL1 with other
proteins, such as CPT1, is the most likely explanation for acyl-
CoA channeling, but evidence for such interaction is lacking.
In summary, the loss of ACSL1 in adipose tissue produced
mice with increased adiposity and severe cold intolerance.
Adipocytes derived from Acsl1A/ mice had normal rates of
FA incorporation into TAG and normal loss of TAG stores
after lipolysis, but had reduced rates of FA oxidation. Although
deficient ACSL1 in liver, which expresses relatively more of
the ACSL4 and ACSL5 isoenzymes, results in only a minor
defect in FA oxidation (Li et al., 2009), we conclude that the func-
tion of ACSL1 in adipose tissue is to activate FA destined for
b-oxidation.EXPERIMENTAL PROCEDURES
Animal Treatment
Acsl1A/ and littermate Acsl1flox/flox control mice were housed in a pathogen-
free barrier facility (12 hr light/dark cycle) in accordance with the UNC IACUC,
with free access to water and food (Prolab RMH 3000 SP76 chow). For the diet
study, mice were fed a low-fat (10%) diet (D12450B, Research Diets; New
Brunswick, NJ) or a high-fat (45%, primarily from lard) diet (D12451) ad libitum
from age 8 to 25 weeks. Weights were measured weekly. Body fat mass was
assessed by magnetic resonance imaging analysis (EchoMRI-100, Echo
Medical Systems, LLC, Houston) in 5-month-old mice. For thermogenesis
experiments, mice were fasted for 4 hr and placed in a 4C environment
without food. Temperature wasmeasured hourly with a rectal probe thermom-
eter (Thermalert TH-5, Physitemp; Clifton, NJ). Mice were removed from
the cold when core temperature dropped below 28C or at 4 hr. Rates of
O2 consumption were determined in Oxymax chambers (Columbus Instru-
ments; Columbus, OH) after mice were acclimated overnight. Data were
collected from mice for 3 hr after saline injection. After isoproterenol or
CL-316243 was injected (10 mg/kg), O2 consumption was measured for an
additional 3 hr, and then plasma was collected in 5% 0.5 M EDTA. Plasma
TAG, b-hydroxybutyrate (Stanbio; Boerme, TX), cholesterol, FFA, glucose
(Wako; Richmond, VA), and free and total glycerol (Sigma. St. Louis) were
measured colorimetrically. Adiponectin was measured by ELISA (Linco;
Billerica, MA). Oral glucose tolerance tests were performed by gavaging
with glucose (2.5 mg/kg body weight) and measuring tail blood glucose at62 Cell Metabolism 12, 53–64, July 7, 2010 ª2010 Elsevier Inc.baseline, 15, 30, 60, and 120 min (One Touch Ultra glucometer, LifeScan,
Inc.; Milpitas, CA).
Enzyme Assays
ACSL initial rates were measured with 50 mM [1-14C]palmitic acid, 10 mM ATP,
and 0.25 mM CoA with total membrane fractions (0.5–4.0 mg) (Polokoff and
Bell, 1978). GPAT was measured with 800 mM [3H]glycerol-3-phosphate and
82.5 mM palmitoyl-CoA (Nagle et al., 2008).
Adipocyte Studies
Adipose explants were isolated and release of FFA and glycerol wasmeasured
(Warne et al., 2006). Epididymal adipocytes were isolated (Varma et al., 2008).
Rates of CO2 and ASM production from [1-
14C]oleate (Perkin Elmer; Waltham,
MA) were measured in aliquots of the reaction mixture after incubating with
0.5ml buffer containing 10 mM [1-14C]oleate for 1.5 hr in a 10% adipocyte solu-
tion. The incubation chamber contained a center well filled with filter paper and
was sealed with a rubber stopper. Carbon dioxide was trapped by adding
200 ml 70% perchloric acid to the reaction mixture and 300 ml of 1 M NaOH
to the center well and incubating the samples at RT for 45 min. The center
well was then placed into scintillation fluid and counted. The acidified reaction
mixture was incubated overnight at 4C and centrifuged at 4000 rpm for 30min
before aliquots of the supernatant were counted for 14C-labeled ASM. For FA
incorporation, a 10% adipocyte solution was incubated with 0.5 ml buffer con-
taining 10 mM [1-14C]oleate and 90 mM unlabeled oleate for 2 hr. Brown and
white preadipocytes from control and Acsl1A/ adipose tissue (Cao et al.,
2001) were differentiated into adipocytes for 7–14 days and exposed to
500 mM oleate with 0.6 mCi [1-14C]oleate per 60 mm dish for 3 hr. Cells were
then harvested, labeled media was removed and replaced with growth media
for 21 hr before cells were harvested, or, after the 21 hr chase, 10 mM isopro-
terenol was added to media for an additional 3 hr before harvest. FAs released
into the media were measured colorimetrically (Wako) in unlabeled control
plates. Total lipid was extracted from the cells into CHCl3 (Bligh and Dyer,
1959). The lipid extract was dried under N2, resuspended in CHCl3, and chro-
matographedwith authentic lipid standards run in parallel on 0.25mmsilica gel
G plates in hexane:ethyl ether:acetic acid (80:20:1; v/v). The 14C-labeled lipids
were detected and quantified with a Bioscan 200 Image System.
FA Oxidation in BAT
Freshly isolated BATwasminced and homogenized with amotor-driven Teflon
pestle and glass mortar in ice-cold buffer A (100 mM KCl, 40 mM Tris-HCl,
10 mM Tris base, 5 mM MgCl2-6H2O, 1 mM EDTA, and 1 mM ATP [pH 7.4])
at a 20-fold dilution (wt/vol) or mitochondria were isolated (Cannon and Neder-
gaard, 2008) and resuspended in buffer A and the rate of [1-14C]palmitate,
[1-14C]palmitoyl-CoA, or [1-14C]pyruvate was measured (Noland et al.,
2007). Isolated BAT mitochondria (20 mg protein) in buffer (70 mM sucrose,
220 mM mannitol, 10 mM KH2PO4, 2 mM MgCl2, 2 mM HEPES, 1 mM
EDTA, 0.1% BSA, 3 mM malate, and 1.3 mg/ml oligomycin) were loaded
onto XF24 plates, and rates of O2 consumption were measured according to
the manufacturer’s instructions with a Seahorse X24F Analyzer (Seahorse
Bioscience; North Billerica, MA) during the consecutive addition at 4 min inter-
vals of 5 mM pyruvate, 2 mM GDP, and 1 mM FCCP.
SUPPLEMENTAL INFORMATION
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